OrthoPediatrics Corp. (KIDS) vs Pacific Biosciences of California, Inc. (PACB)
OrthoPediatrics Corp. and Pacific Biosciences of California, Inc. are both Medical Devices companies. OrthoPediatrics Corp. is the larger, with a market value of $591.1M against $484.9M — 1.2× the size. OrthoPediatrics Corp. grew revenue faster over the last twelve months: 14.5% against 2.02%. OrthoPediatrics Corp. has the higher net margin (−15.7% vs −82.5%) and the higher return on invested capital (−4.77% vs −22.2%). Across the 17 metrics below, OrthoPediatrics Corp. leads on 15 and Pacific Biosciences of California, Inc. on 2.
Valuation
Profitability
| Metric | KIDS | PACB | Medical Devices median |
|---|---|---|---|
| Gross margin | 73.65% | 36.38% | 56.01% |
| Operating margin | (11.87%) | (83.53%) | (15.03%) |
| Net margin | (15.72%) | (82.49%) | (20.40%) |
| Free cash flow margin | (0.73%) | (50.53%) | (7.24%) |
| Return on equity | (11.36%) | (929.31%) | (15.32%) |
| Return on assets | (7.83%) | (16.66%) | (19.72%) |
| Return on invested capital | (4.77%) | (22.22%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack